Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 20, 2005
J Am Soc Nephrol 16: 2778-2788, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005040392

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005040392v1
16/9/2778    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ayus, J. C.
Right arrow Articles by Lee, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ayus, J. C.
Right arrow Articles by Lee, S.

Clinical Dialysis

Effects of Short Daily versus Conventional Hemodialysis on Left Ventricular Hypertrophy and Inflammatory Markers: A Prospective, Controlled Study

Juan Carlos Ayus*, M. Reza Mizani*, Steven G. Achinger*, Ravi Thadhani{dagger}, Alan S. Go{ddagger},§ and Shuko Lee||

* Division of Nephrology, University of Texas Health Science Center, San Antonio, Texas; {dagger} Renal Unit, Massachusetts General Hospital, Boston, Massachusetts; {ddagger} Division of Research, Kaiser Permanente of Northern California, Oakland, California; § Departments of Epidemiology, Biostatistics, and Medicine, University of California, San Francisco, California; and || Research and Development Service, South Texas Veterans Health Care System, Audie L. Murphy Division, San Antonio, Texas

Address correspondence to: Dr. Juan Carlos Ayus, Director of Dialysis Services, Texas Diabetes Institute, University of Texas Health Science Center San Antonio, Mail Code 7882, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900. Phone: 210-232-1911, Fax: 210-358-7328; ayus{at}uthscsa.edu

Received for publication April 13, 2005. Accepted for publication June 22, 2005.

Left ventricular hypertrophy (LVH) and inflammation independently increase risk for death in people who receive hemodialysis. A nonrandomized, controlled trial was conducted of the effect of short daily (6 sessions/wk of 3 h each) or conventional (three sessions/wk of 4 h each) hemodialysis on LVH and inflammatory factors. A total of 26 short daily hemodialysis and 51 matched conventional hemodialysis patients were enrolled, and baseline and 12-mo measures of echocardiographic left ventricular mass index (LVMI), serum C-reactive protein (CRP), serum calcium and phosphorus, and erythropoietin resistance index were collected. Baseline characteristics were similar between groups except that hemoglobin and serum calcium were lower and serum phosphorus was higher in the short daily hemodialysis group. At 12-mo follow-up, short daily hemodialysis patients experienced a 30% decrease in LVMI (154 ± 33 to 108 ± 25; P < 0.0001). After adjustment for potential confounders, short daily hemodialysis ({beta} = –41.63, P = 0.03) and percentage decrease in serum phosphorus ({beta} = –0.12, P = 0.04) predicted a 12-mo decrease in LVMI. Among short daily hemodialysis patients, there were significant reductions in median CRP levels [1.22 interquartile range (IQR) (0.37 to 3.70) to 0.05 IQR (0.05 to 1.17); P < 0.01] and erythropoietin resistance index [19.5 IQR (8.6 to 37.6) to 10.5 IQR (5.5 to 14.6); P < 0.001]. There were no significant changes in LVMI, CRP, or erythropoietin resistance index in the conventional hemodialysis group. Short daily hemodialysis is associated with improved fluid and phosphorus management and a reduction in LVH and inflammatory factors compared with conventional hemodialysis. Future trials are needed to determine whether short daily hemodialysis can reduce morbidity and mortality in this high-risk population.




This article has been cited by other articles:


Home page
NDT PlusHome page
A. L. M. de Francisco, P. Stenvinkel, and S. Vaulont
Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness
NDT Plus, January 1, 2009; 2(suppl_1): i18 - i26.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. M. Kjellstrand, U. Buoncristiani, G. Ting, J. Traeger, G. B. Piccoli, R. Sibai-Galland, B. A. Young, and C. R. Blagg
Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3283 - 3289.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. P. Lee, S. A. Zenios, and G. M. Chertow
Cost-Effectiveness of Frequent In-Center Hemodialysis
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1792 - 1797.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Punal, L. V. Lema, D. Sanhez-Guisande, and A. Ruano-Ravina
Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: a systematic review
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2634 - 2646.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Bodyak, J. C. Ayus, S. Achinger, V. Shivalingappa, Q. Ke, Y.-S. Chen, D. L. Rigor, I. Stillman, H. Tamez, P. E. Kroeger, et al.
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals
PNAS, October 23, 2007; 104(43): 16810 - 16815.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
B. F. Culleton, M. Walsh, S. W. Klarenbach, G. Mortis, N. Scott-Douglas, R. R. Quinn, M. Tonelli, S. Donnelly, M. G. Friedrich, A. Kumar, et al.
Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial
JAMA, September 19, 2007; 298(11): 1291 - 1299.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. G. Achinger and J. C. Ayus
Left Ventricular Hypertrophy: Is Hyperphosphatemia among Dialysis Patients a Risk Factor?
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S255 - S261.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. S. MacGregor, J. W. M. Agar, and C. R. Blagg
Home haemodialysis--international trends and variation
Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1934 - 1945.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton
CHAPTER 5: Frequent and Sustained Hemodialysis
J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S24 - S27.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP